HOME >> BIOLOGY >> NEWS
Dartmouth bioengineers develop humanized yeast

Hanover, N.H. Bioengineers at Dartmouth have genetically engineered yeast to produce humanized therapeutic proteins to address the manufacturing crunch currently confronting the biopharmaceutical industry. Reported in this week's issue of Science, the researchers have re-engineered the yeast P. pastoris to secrete a complex human glycoprotein--a process offering significant advantages over current production methods using mammalian cell lines, according to the researchers.

The study, titled "Production of Complex Human Glycoproteins in Yeast," is one result of a collaboration between researchers at Dartmouth's Thayer School of Engineering and GlycoFi, Inc., a biotech company located in Lebanon, New Hampshire. Founded in the spring of 2000 by Dartmouth engineering professors Tillman Gerngross and Charles Hutchinson, GlycoFi is advancing technology for the production of humanized proteins using fungal-based expression systems.

"For the first time, we have shown that yeast can be used to produce a complex human glycoprotein," says Professor Gerngross. "This technology has the potential to revolutionize the way therapeutic proteins are made--better, cheaper, faster, safer--and offer a level of control over the quality of the end product that has never existed before."

Proteins for pharmaceuticals must be manufactured by living cells. These cells are genetically engineered to produce (or express) proteins that mimic the ones synthesized by humans. These proteins can then be used to treat diseases ranging from cancer and multiple sclerosis to hemophelia and renal disease.

Current production of these therapeutic proteins, however, is limited by capacity due to rapid growth in the discovery of protein-based therapies--to the point that some approved drugs cannot be produced in adequate amounts, and still others are not making it into commercialization due to cost-prohibitive production methods.

"This development is very ti
'"/>

Contact: Sue Knapp or Catha Lamm
sue.knapp@dartmouth.edu
603-646-3661
Dartmouth College
28-Aug-2003


Page: 1 2

Related biology news :

1. Dartmouth Medical School awarded $9 million grant for genomics research
2. Dartmouth study advances prion disease research
3. Dartmouth researchers find two circadian clocks in the same plant tissue
4. Dartmouth engineers closer to mass-producing therapeutic proteins
5. Arsenic in drinking water may be linked to cancer Dartmouth study finds
6. Dartmouth researchers put recycling in perspective
7. Dartmouth Medical School geneticists discover new role for antisense RNA
8. Dartmouth researchers identify multi-tasking circadian protein
9. New way found to see light through novel protein identified by Dartmouth geneticists
10. Cancer killing gene found by Dartmouth researchers
11. Dartmouth biologists say algae might be missing mercury link in aquatic food chain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/5/2018)... ... October 04, 2018 , ... ... of Illinois Extension and Monroe County Economic Development Corporation (EDC), has been ... of Food and Agriculture (NIFA) Non-Land Grant College of Agriculture (NLGCA) Capacity-Building ...
(Date:10/3/2018)... ... October 03, 2018 , ... Fit4D, a leading ... of healthcare visionary, Jimmy Lee, as Strategic Advisor to the company’s board. Mr. ... industry experience. As a Senior Executive at Anthem, he had P&L accountability for ...
(Date:10/2/2018)... ... 02, 2018 , ... Through this webinar, sponsored by Molecular Devices , ... learn the role of calcium kinetics in cardiac safety testing. The speakers for this ... Biography; and Tsang Wai Lam, an assay development scientist at PPSC. , They will ...
Breaking Biology News(10 mins):
(Date:10/17/2018)... ... October 17, 2018 , ... Dr. ... his associate, Dr. Michael Kang, are offering current and new patients the opportunity ... thanks to the emerging, proven treatment technology known as Piezosurgery® . As ...
(Date:10/16/2018)... ... 2018 , ... Infinity Healing Center, along with sixteen other ... that effectively treats pain, reduces the need for opioids, and lowers healthcare costs. ... photobiomodulation (PBM) has been effective for the treatment of medical conditions like Lyme, ...
(Date:10/11/2018)... ... October 10, 2018 , ... ... announces the appointment of Wendy Nelson, PhD, as its new CEO. , Dr. ... experience in the biotech industry. Most recently, Dr. Nelson was VP of ...
(Date:10/5/2018)... CITY, Calif. (PRWEB) , ... October 04, 2018 ... ... infectious disease diagnostics with genomics, along with Duke University, announced today at IDWeek™ ... non-invasive blood test that detects pathogen DNA in plasma, accurately identified causative pathogens ...
Breaking Biology Technology:
Cached News: